Arie Belldegrun, M.D., FACS
Board Member
UroGen Pharma Ltd. (URGN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Arie Belldegrun, M.D., FACS
Arie Belldegrun, M.D., FACS is recorded as Board Member at UroGen Pharma Ltd. (URGN). UroGen Pharma Ltd. reported in an 8-K filed August 8, 2024 that Arie Belldegrun, M.D., FACS was appointed director, effective August 6, 2024. UroGen Pharma Ltd. reported in an 8-K filed September 11, 2023 that Arie Belldegrun, M.D., FACS was appointed Director, effective September 7, 2023.
“The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”
“The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-09-07–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at UroGen Pharma Ltd.
Other people whose current roles at this company are on record from its filings.
- Elizabeth Barrett CEO, Board Member
- Arie Belldegrun Chairman, Board Member
- Chris Degnan CFO
- Dong (Don) Kim CFO
- Stephen L. Mullennix COO
- Jason Smith General Counsel
- Christopher Degnan Chief Accounting Officer
- Arie Belldegrun, M.D. Board Member
- Cynthia M. Butitta Board Member
- Daniel G. Wildman Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.